Overview
Boutonneuse fever, caused by Rickettsia conorii, is a tick-borne rickettsial infection characterized by an eschar (tache noire) at the site of inoculation, fever, rash, and regional lymphadenopathy. 1Diagnosis
Clinical Presentation: Presence of an eschar (tache noire), fever, rash, and lymphadenopathy.
Laboratory Tests: Serological tests (IFA, ELISA) for Rickettsia conorii antibodies.
Histopathology: Skin biopsy of eschar showing lymphohistiocytic vasculitis and dermal edema. 1Management
First-line Treatment: Doxycycline (adult dose: 100 mg orally twice daily for 5-7 days). 1 (Evidence: Expert opinion)
Alternative for Children <8 Years: Tetracycline (dosage adjusted for age). 1 (Evidence: Expert opinion)
Adjunctive Measures: Supportive care including hydration, antipyretics, and monitoring for complications. 1 (Evidence: Expert opinion)Special Populations
Pregnancy: Doxycycline contraindicated; alternatives include tetracyclines (if necessary) with caution; close monitoring required. 1 (Evidence: Expert opinion)
Pediatrics: Use age-adjusted doses of tetracyclines; doxycycline reserved for older children due to teeth and bone development concerns. 1 (Evidence: Expert opinion)
Elderly: Standard treatment regimens apply; close monitoring for renal function due to potential drug interactions. 1 (Evidence: Expert opinion)Key Recommendations
Confirm diagnosis using serological tests and histopathological examination of eschar lesions. (Evidence: Moderate) 1
Initiate treatment with doxycycline as first-line therapy for adults; adjust for pediatric patients based on age. (Evidence: Expert opinion) 1
Avoid doxycycline in pregnant women; consider alternative tetracyclines with caution and close monitoring. (Evidence: Expert opinion) 1References
1 Walker DH, Occhino C, Tringali GR, Di Rosa S, Mansueto S. Pathogenesis of rickettsial eschars: the tache noire of boutonneuse fever. Human pathology 1988. link80238-7)